THE RELATIONSHIP BETWEEN ESR AND C-REACTIVE PROTEIN WITH VARIABLE LEVEL OF D-DIMER IN COVID-19

Husam Abdulkareem Hasan1, Nawfal Almubarak1, Murtadha A Jeber1

  • 1DEPARTMENT OF SURGERY, BASRAH MEDICAL COLLEGE, UNIVERSITY OF BASRAH, BASRAH, IRAQ.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|January 21, 2022
PubMed

Insights

In COVID-19 patients, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels show a moderate positive correlation with D-Dimer. This suggests inflammatory markers can help predict D-Dimer increases in SARS-CoV-2 infection.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Hematology

Background:

  • COVID-19, caused by SARS-CoV-2, is associated with a significant inflammatory response.
  • Elevated D-Dimer levels are common in severe COVID-19 cases, indicating a hypercoagulable state.
  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are key inflammatory markers.

Purpose of the Study:

  • To investigate the correlation between inflammatory markers (ESR, CRP) and D-Dimer levels in patients with COVID-19.
  • To assess the potential of ESR and CRP as predictors of D-Dimer elevation in SARS-CoV-2 infection.

Main Methods:

  • A study involving 74 patients (both genders) admitted to Al-Mawani teaching hospital between August and October 2020.
  • Collection of demographic data and measurement of inflammatory markers (ESR, CRP) and D-Dimer on the day of hospital admission.

Main Results:

  • A moderate positive correlation was observed between D-Dimer and ESR (r = 0.354, p = 0.002).
  • A moderate positive correlation was found between D-Dimer and CRP (r = 0.457, p < 0.05).
  • No significant relationship was found between demographic data and D-Dimer levels.

Conclusions:

  • In SARS-CoV-2 infection, ESR and CRP levels are moderately positively correlated with D-Dimer.
  • Increasing levels of ESR and CRP may help predict concurrent increases in D-Dimer.
  • These inflammatory markers can aid in predicting D-Dimer changes in COVID-19, provided other inflammatory conditions are excluded.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
102
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
55
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
38